Directory › Sharp Services
Sharp Services — Allentown
Allentown, Pennsylvania, United States · CDMO
Site facts
- Company
- Sharp Services
- Name(s) in FDA data
- Sharp Packaging Services, LLC
- FEI number(s)
- 3004161147 (present in FDA Data Dashboard records for this name and city)
- Location (as in FDA data)
- Allentown, Pennsylvania, United States 18106
- Records matched
- 12 FDA inspections · 2 inspections with posted 483 citations
- Most recent FDA inspection in dataset
- 22 Apr 2026 — NAI
Capabilities (from the company's website)
- Oral solid dose
…dministration (DEA) schedule II drug vault Contract Services Primary packaging Bottling – oral solid dose drug products Pouching – solid dose, powder Secondary packaging Cartoning and kittin…
- Clinical trial supply & packaging
…ontent Allentown, PA, US - Building 1 The global headquarters of Sharp, and our Specialty Packaging Center of Excellence, is located at our Allentown campus and offers a breadth of primary…
Taken from the company's web page for this site. Source: https://www.sharpservices.com/facilities/building-1-allentown-us/, checked 16 Oct 2026. Quoted text shows the wording each tag is based on.
Regulatory timeline
Newest first. Each entry links to the published source. Inspection classifications: NAI = no action indicated, VAI = voluntary action indicated, OAI = official action indicated (FDA definitions). Posted 483 citations are FDA's short summaries, not the full Form 483.
-
22 Apr 2026FDA inspection FDA inspection classified NAI
No Action Indicated (NAI). Product type(s): Biologics. Project area(s): Vaccines and Allergenic Products.
Source: FDA Data Dashboard – Inspections (FEI 3004161147, inspection ID 1314200)
-
21 Nov 2025FDA inspection FDA inspection classified NAI
No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.
Source: FDA Data Dashboard – Inspections (FEI 3004161147, inspection ID 1283904)
-
28 Jan 2022Form 483 observations 13 posted Form 483 citation(s)
Citation summaries (13)
- 21 CFR 211.103: Actual vs. theoretical yields not determined
- 21 CFR 211.110(a): Control procedures to monitor and validate performance
- 21 CFR 211.125(d): Destruction of excess labels with lot numbers
- 21 CFR 211.130(e): Packaging line inspection before use
- 21 CFR 211.142: Written warehousing procedures established/followed
- 21 CFR 211.188(a): Accurate reproduction
- 21 CFR 211.192: Written record of investigation incomplete
- 21 CFR 211.198(b)(2): Complaint Investigation/Follow-Up Findings
- 21 CFR 211.22(a): Approve or reject components, products
- 21 CFR 211.22(d): Procedures not in writing, fully followed
- 21 CFR 211.42(a): Buildings of Suitable Size, Construction, Location
- 21 CFR 211.63: Equipment Design, Size and Location
- 21 CFR 211.68(b): Backup file not maintained
Source: FDA Data Dashboard – Citations (FEI 3004161147, inspection ID 1161256)
-
28 Jan 2022FDA inspection FDA inspection classified VAI
Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.
Source: FDA Data Dashboard – Inspections (FEI 3004161147, inspection ID 1161256)
-
24 Apr 2019Form 483 observations 1 posted Form 483 citation(s)
Citation summaries (1)
- 21 CFR 211.184(b): Component Test Records
Source: FDA Data Dashboard – Citations (FEI 3004161147, inspection ID 1087516)
-
24 Apr 2019FDA inspection FDA inspection classified VAI
Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.
Source: FDA Data Dashboard – Inspections (FEI 3004161147, inspection ID 1087516)
-
13 Aug 2018FDA inspection FDA inspection classified NAI
No Action Indicated (NAI). Product type(s): Devices, Drugs. Project area(s): Compliance: Devices; Drug Quality Assurance.
Source: FDA Data Dashboard – Inspections (FEI 3004161147, inspection ID 1070357)
-
03 Feb 2017FDA inspection FDA inspection classified NAI
No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.
Source: FDA Data Dashboard – Inspections (FEI 3004161147, inspection ID 1002333)
-
19 Jun 2014FDA inspection FDA inspection classified NAI
No Action Indicated (NAI). Product type(s): Devices. Project area(s): Project Evaluation: Devices.
Source: FDA Data Dashboard – Inspections (FEI 3004161147, inspection ID 883821)
-
15 Jan 2014FDA inspection FDA inspection classified VAI
Voluntary Action Indicated (VAI). Product type(s): Drugs, Food/Cosmetics, Veterinary. Project area(s): Drug Quality Assurance; Food Composition, Standards, Labeling and Econ; Monitoring of Marketed Animal Drugs, Feed, and Devices.
Source: FDA Data Dashboard – Inspections (FEI 3004161147, inspection ID 862935)
-
21 Feb 2013FDA inspection FDA inspection classified NAI
No Action Indicated (NAI). Product type(s): Devices. Project area(s): Compliance: Devices.
Source: FDA Data Dashboard – Inspections (FEI 3004161147, inspection ID 820216)
-
23 Jan 2012FDA inspection FDA inspection classified NAI
No Action Indicated (NAI). Product type(s): Devices. Project area(s): Compliance: Devices; Postmarket Assurance: Devices.
Source: FDA Data Dashboard – Inspections (FEI 3004161147, inspection ID 763030)
-
13 Apr 2011FDA inspection FDA inspection classified NAI
No Action Indicated (NAI). Product type(s): Drugs, Food/Cosmetics, Veterinary. Project area(s): Drug Quality Assurance; Food Composition, Standards, Labeling and Econ; Monitoring of Marketed Animal Drugs, Feed, and Devices.
Source: FDA Data Dashboard – Inspections (FEI 3004161147, inspection ID 719565)
-
29 Jul 2009FDA inspection FDA inspection classified NAI
No Action Indicated (NAI). Product type(s): Food/Cosmetics. Project area(s): Food Composition, Standards, Labeling and Econ; Foodborne Biological Hazards.
Source: FDA Data Dashboard – Inspections (FEI 3004161147, inspection ID 618027)
This is a record of what regulators published, not a rating. Absence of a record here does not mean no record exists; see methodology for what we check and how records are matched.